212 related articles for article (PubMed ID: 104538)
21. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
Blanchy S; Galtier J
Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
[No Abstract] [Full Text] [Related]
22. Sensitivity and specificity of methods of classification of leprosy without use of skin-smear examination.
Croft RP; Smith WC; Nicholls P; Richardus JH
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):445-50. PubMed ID: 10347564
[No Abstract] [Full Text] [Related]
23. Clofazimine-resistant leprosy, a case report.
Warndorff-van Diepen T
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):139-42. PubMed ID: 6749703
[No Abstract] [Full Text] [Related]
24. Experimental chemotherapy in leprosy, then and now.
Shepard CC
Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
[No Abstract] [Full Text] [Related]
25. Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy.
Suneetha S; Arunthathi S; Kurian N; Chacko CJ
Acta Leprol; 2000-2001; 12(1):11-8. PubMed ID: 11526636
[TBL] [Abstract][Full Text] [Related]
26. Leprosy of the upper respiratory tract. A clinical bacteriological, histopathological and histochemical study of twenty cases.
Yassin A; el Shennawy M; el Enany G; Wassef NF; Shoeb S
J Laryngol Otol; 1975 May; 89(5):505-11. PubMed ID: 1097553
[TBL] [Abstract][Full Text] [Related]
27. Lesion lodgement in leprosy.
Skinsnes OK
Int J Lepr Other Mycobact Dis; 1978; 46(2):204-15. PubMed ID: 355160
[No Abstract] [Full Text] [Related]
28. Effect of rifampin, clofazimine, and B1912 on the viability of Mycobacterium leprae in established mouse footpad infection.
Holmes IB; Banerjee DK; Hilson GR
Proc Soc Exp Biol Med; 1976 Apr; 151(4):637-41. PubMed ID: 772686
[TBL] [Abstract][Full Text] [Related]
29. The chemotherapy of leprosy. Part 1.
Ellard GA
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
[No Abstract] [Full Text] [Related]
30. Studies on healthy contacts of leprosy patients--a preliminary report.
Ramu G; Malaviya GN; Bharadwaj VP; Sengupta U; Sinha S; Ramanathan VD; Pal C; Desikan KV
Indian J Lepr; 1985; 57(4):796-803. PubMed ID: 3915008
[TBL] [Abstract][Full Text] [Related]
31. [The lymphocyte transformation test using phytohemagglutinin, lepromin and M. leprae in lepromin-negative and positive leprosy: prognostic value compared with that of lepromin].
Pagnano PM; Bechelli LM; de Lima Filho EC
Acta Leprol; 1982; (86-87):83-95. PubMed ID: 6816002
[No Abstract] [Full Text] [Related]
32. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
Reyes-Javier PD; Tantiongco PR
Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
[No Abstract] [Full Text] [Related]
34. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
Languillon J; Yawalkar SJ; McDougall AC
Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
[No Abstract] [Full Text] [Related]
35. [Case of lepromatous neuritis--a study of neural lesions by neural biopsy].
Inoue N; Ota M; Tabira T; Shida K; Goto I
Rinsho Shinkeigaku; 1973 Oct; 13(10):658-63. PubMed ID: 4798266
[No Abstract] [Full Text] [Related]
36. [Immunologic and histomorphologic features of responsiveness in patients with leprosy at different stages of treatment].
Strukov AI; Babaiants RS; Shakhtmeĭster IIa; Kopieva TN; Goloschapov NM
Vestn Dermatol Venerol; 1972 Oct; 46(10):8-12. PubMed ID: 4569353
[No Abstract] [Full Text] [Related]
37. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
38. Chemotherapy of leprosy in multibacillary nude mice.
Hastings RC; Chehl SK
Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
[No Abstract] [Full Text] [Related]
39. How much non-infectious are the "non-infectious" lepromatous leprosy patients?
Prabhakar MC; Appa Rao AV; Krishna DR; Ramanakar TV
Lepr India; 1983 Jul; 55(3):576-83. PubMed ID: 6361383
[TBL] [Abstract][Full Text] [Related]
40. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
